Sort   by:  
 Page size 
UnknownProgrammed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study.
Not available
S-EPMC5593697 | biostudies-literature
UnknownTaxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis.
Not available
S-EPMC10142155 | biostudies-literature
UnknownPrimary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion Lymphoma.
Not available
S-EPMC11803546 | biostudies-literature
UnknownIntegrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma.
Not available
S-EPMC10238838 | biostudies-literature
UnknownClinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study.
Not available
S-EPMC10950431 | biostudies-literature
UnknownTime-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.
Not available
S-EPMC8777559 | biostudies-literature
UnknownBurkitt Lymphoma International Prognostic Index.
Not available
S-EPMC9851706 | biostudies-literature
UnknownClinical portrait of the SARS-CoV-2 epidemic in European cancer patients.
Not available
S-EPMC7668225 | biostudies-literature
UnknownCOVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
Not available
S-EPMC9047221 | biostudies-literature
UnknownSARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
Not available
S-EPMC9991062 | biostudies-literature
Sort   by:  
 Page size